Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiotherapy and PBSC Support for High-Risk PNET
NCT00003846Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Jul 1999
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa in primitive neuroectodermal tumor (PNET), sponsored by Children's Oncology Group. Started Jul 1999; status: completed.
02
Drugs
thiotepa
03
Conditions
primitive neuroectodermal tumor (PNET)
Beyond the preview
Go deeper on NCT00003846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003846.